Chief Medical Officer Trang Ly said the system, which allows people to manage Type 2 diabetes without bolusing, will be ...
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced ...
Medical Device Network on MSN
Insulet reports new data for Omnipod 6 and FCL systems
Findings from the STRIVE study indicated improved glycaemic control with Omnipod 6 compared to Omnipod 5.
Insulet has begun shipping Omnipod 5 pods with the new algorithm to US retailers ahead of a broader software update.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
STRIVE pivotal trial shows Omnipod 6 achieved strong glycemic outcomes with fewer boluses, across age groups and diabetes types EVOLUTION 3 feasibility study demonstrates improved time in range using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results